« Return to News | Ethics/Regulatory | Drug Sponsors

Anulex Techonologies will layoff workers

Wednesday, April 20, 2011 11:28 AM

Minnesota-based Anulex Techonologies will layoff workers after receiving a warning letter from the FDA in February, 2011, according to Fierce Medical Devices. 

The FDA reported finding "objectionable conditions" during an Aug. 23-Sept. 22, 2010 inspection of the company's facility. The warning letter also states that the company failed to submit an IDE application and receive FDA approval prior to allowing patients to participate in a study of the Xclose soft tissue repair system for annulus fibrosus repair. Additionally, the FDA cited Anulex for promoting Xclose for annulus fibrosus repair before FDA approval for commercial distribution. 

Anulex president and general manager Tim Miller denies having prior knowledge of needing to obtain an IDE, according to Fierce Medical Devices.

The company has stopped Xclose marketing for spinal procedures, which led to the layoffs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.